Final-Program-ATS-2023-AP.vp

60

SUNDAY • MAY 21

P76 Paraneoplastic Dermatomyositis Syndrome Presenting As Pulmonary Connective Tissue Disease/ E. Bak, Louisville, KY P77 Pulmonary Renal Syndrome in Pauci-immune ANCA Positive Vasculitis/ K. Shah, Athens, GA P78 Bilateral Infiltrates On Chest X-Ray-Thinking Outside The Box/ C.L. Weldrick, Galway, Ireland P79 Medium Vessel Vasculitis Presenting As Progressive Pulmonary Nodules/ C.M. Fiore, Worcester, MA P80 IgG4-Related Lung Lesion Presenting as Lung Mass/ S. Nair, Omaha, NE P81 Rare Pulmonary Manifestations Of Ankylosing Spondylitis/ S. Chandna, Cleveland, OH P82 An Equivocal Presentation of Anti Neutrophil Cytoplasmic Antibodies (ANCA)-negative Eosinophilic Granulomatosis With Polyangiitis/ A. Mathew, Stockton, CA P83 First Impressions Can Be Elusive: A Case of EJ+ Idiopathic Inflammatory Myopathy Flare Mimicking Metastatic Lung Cancer/ S. Shimizu, Cleveland, OH P84 Atypical Presentation Of Rhinovirus Infection With Rapid Deterioration Requiring Mechanical Ventilation/ T. Simpson, New York, NY P85 Finding a Diagnosis in the Woods: A Case of Anti-Glomerular Basement Membrane Antibodies and Pauci-immune Glomerulonephritis With Blastomycosis/ K.E. Berry, Chicago, IL P86 Repeated Whole Lung Lavage With Extracorporeal Membrane Oxygenation Assistance and Multimodal Medical Therapy in Severe Pulmonary Alveolar Proteinosis/ C. Provenza, Memphis, TN P87 Hypoventilation Syndrome as a Scleroderma Variant With Myositis: A Novel Manifestation Attributed to COVID/ A. Gubran, Brooklyn, NY P88 Avoiding Diagnostic Closure: A Case Of PJP That Wasn’t/ S. Sasmal, Columbus, OH P89 A Case of Lofgren Syndrome Incited by Covid-19 Vaccination/ A.J. Pronko, New York, NY P90 Whipple’s Disease Diagnosed By Pulmonary Manifestations in a Young Adult With Autoimmune Disease/ K. Richard, Boston, MA

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A33

LATE BREAKING ADVANCES IN ASTHMA AND IMMUNOLOGY

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area A, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators.

P92 Mitochondrial DNA-toll-likeReceptor 9 InteractionsDrives Fibrosis in theAdult Lung/ C. Ryu, NewHaven, CT P93 Sphingosine 1 Phosphate Signaling Pathway Drives Female Asthma Susceptibility/ E. Granato, Naples, Italy P94 First-in-class Inhalable Anti-TSLP Single Domain Antibody With Therapeutic Potential in Asthma Treatment/ Y. Wan, Shanghai, China P95 Phase I Safety and Efficacy Evaluation of the First-in-class Inhalable Anti-IL-4R a Single Domain Antibody/ Y. Wan, Shanghai, China P96 First-in-class Inhalable Anti-notch2 Single Domain Antibody for the Treatment of Cystic Fibrosis Lung Disease/ Y. Wan, Shanghai, China P97 ETI Triple Therapy Shows Sustained, Progressive Normalisation of Airway Cytokine and Antiprotease Balance and Systemic Inflammation Over One Year of Treatment/ M.P. Murphy, Dublin, Ireland P98 DNA Methylation of Leucine Aminopeptidase 3 (LAP3) at Birth Mediates the Association of Maternal Gestational Metabolites to Childhood Lung Function/ N. Mukherjee, Little Rock, AR P99 Long-term Alteration of Alveolar Epithelial Cells After Early-life RSV Infection/ W. Fonseca, Ann Arbor, MI P100 Oxidized Low Density Lipoprotein Mediates NLRP3 Activation in Patients With Sleep Apnea and Early Subclinical Atherosclerosis/ E. Díaz, Madrid, Spain P101 E-Cigarette Vape Impairs Lung Endothelial Barrier Function and Autophagy via Jun N-Terminal Kinase/ T. Rivera, Denver, CO P102 Protracted Pulmonary Inflammation in IFN-gamma Deficient Mice Recovering From Cytokine Release Syndrome/ G. Rajagopalan, New Haven, CT P103 Human v g 2v d 2 T Cells Attenuate Collagen Type I Expression in Lung Fibroblasts By Inhibiting Myocardin Expression/ D. Okuno, Nagasaki, Japan

ATS 2023 • Washington, DC